Nature Medicine, Published online: 07 May 2025; doi:10.1038/d41591-025-00030-y
After years of false starts, metabolic dysfunction-associated steatohepatitis is finally seeing therapeutic breakthroughs — from the first approved drug to candidates that reverse cirrhosis.
